Visceral metastases in prostate cancer: an underestimated and understudied subgroup

Authors :: Maria T Bourlon
Thomas W. Flaig
Source :: ONCOLOGY. :980-986
Publication Year :: 2014
Publisher :: MJH Life Sciences, 2014.
Abstract: While evidence points to benefit from highly active hormonal agents in prostate cancer with visceral involvement, the usefulness of immunotherapy is much less clear.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
medicine.medical_treatment
Immunotherapy
medicine.disease
Prostate cancer
Text mining
Internal medicine
medicine
business
Genitourinary Cancers

Full Text Access

Tools